Guizhou Province plans to lay out a blueprint for the development of new pharmaceutical industry

As a "sister chapter", the new pharmaceutical industry must have the same strength, level and effect as the big data industry This is the consensus reached at the new pharmaceutical industry development conference in Guizhou Province held yesterday How to lay out a blueprint for the development of new pharmaceutical industry? At the meeting, it was proposed that we should pool our strength to form a joint force, work hard and solve the "last mile" of policy implementation Specifically around "grasp where", "grasp what", "how to grasp" three issues to come up with practical, practical, and practical results "Grasp where": focus on "one core and seven key points" to define key development areas In August this year, the provincial government issued "guidance on accelerating the development of new pharmaceutical industry" and "new pharmaceutical industry development plan of Guizhou Province", which became the direction policy for the development of new pharmaceutical industry and was built as a "sister part" of big data But at present, compared with the development of big data industry, the new pharmaceutical industry does not match the positioning of "sister chapter" in terms of work promotion and implementation effect, neither "go hand in hand" nor "equal" In view of this, we must "catch up" Yesterday, Guizhou Province held a working conference on the development of new pharmaceutical industry, which proposed that the development of new pharmaceutical industry in Guizhou should be based on the idea of "one core, seven key points" "One core" is to build a "Guiyang new medicine industry circle" with Yibai, Wudang, Xiuwen, Qingzhen, Longli and Gui'an as the radiation points, driven by central Guizhou, as the core gathering area of new medicine industry in the whole province "Seven key points" are Honghuagang, Dafang, Xixiu, Kaili, Shibing, Danzhai and Xingyi They have certain comparative advantages in resources and industrial development foundation, and are the key development areas of new pharmaceutical industry in the province According to the above-mentioned conditions, such as the pharmaceutical industry foundation, development focus and direction, the enthusiasm of local governments, policies and measures, etc., we will focus on the support, make the new medicine become a regional pillar industry and a new economic growth pole as soon as possible, and promote the new medicine industry of the whole province to a higher level "What to grasp": journalists from large enterprises, large varieties, large projects and large parks learned from the meeting that it is the first task and urgent task for Guizhou Province to focus on supporting a number of leading enterprises and rapidly expand the total industry Specifically: first of all, we will take nine large pharmaceutical enterprises including Yibai pharmaceutical and Guizhou bailing as the first cultivation matrix, and strive to cultivate them into a leading and demonstrative new pharmaceutical enterprise group of more than 5 billion yuan level by 2017 Secondly, we will focus on the cultivation of a number of large varieties and advantageous varieties to occupy the market with varieties and create benefits with varieties, so as to become the cornerstone to support the development of new pharmaceutical enterprises and industrial cultivation Once again, we will speed up the introduction of a number of large projects, continue to increase investment promotion in key pharmaceutical areas outside the Yangtze River Delta, the Pearl River Delta, the Bohai rim and the three eastern provinces, and strive to implement specific projects in the fields of proprietary Chinese medicine, ethnic medicine, chemical pharmacy, biological products, medical devices, etc., so as to increase the total amount of Guizhou's pharmaceutical industry Finally, we will speed up the construction of a number of large parks, focus on building a number of new pharmaceutical industrial parks, such as Yibai, Wudang, Xiuwen, Qingzhen, Longli, Gui'an, etc., encourage new pharmaceutical industrial parks to innovate system and mechanism, explore the construction of joint-stock system, enterprise operation, appropriate government subsidies, and functional service platforms, so as to better provide high-level services for enterprises "How to grasp": stick to the practical measures, do practical work and achieve actual results How to implement the policies and measures to solve the bottleneck of the development of new pharmaceutical industry? The meeting proposed that all levels of governments and functional departments strive to make practical recruitment, practical work and effective results     Including focusing on major special activities, organizing investment promotion backbones, concentrating human and material resources, connecting with large enterprises and groups in the field of medicine at home and abroad, realizing benefit and resource sharing; promoting enterprise merger and reorganization, making use of the advantages of market, talents, technology and other advantages of large enterprises, increasing the drug varieties of enterprises in Guizhou; strengthening policy and financial support, and providing key pharmaceutical products in Guizhou Province Species, emergency reserve species, protected species of traditional Chinese medicine and patented drugs shall be given preferential policies; key areas, key enterprises, key species, key projects and key parks for the cultivation and development of new pharmaceutical industry shall be given preferential arrangement of national support projects and strong support by key inclined means of park construction projects At the end of yesterday's meeting, Li Baofang, director of the provincial economic and Information Technology Commission, signed a strategic cooperation agreement with Huang Li, President of Guizhou branch of industrial and Commercial Bank of China, to solve the financing problem of Guizhou pharmaceutical enterprises The meeting pointed out that the provincial Party committee and the provincial government clearly required that the new medicine and big health industry should be built into a "sister chapter" of big data industry, and all departments in all regions should attach great importance to it Focusing on "making large-scale, strong varieties and excellent structure", they should focus on the key links of the new medicine industry chain "building chain", the advantageous links "strengthening chain" and the weak links "complementing chain", Drive the upstream and downstream enterprises to gather and generate projects, and promote the industrial cluster, differentiation and characteristic development The meeting stressed that at present, we should focus on the project construction as the main starting point, rely on the "one billion" project and the "government enterprise bank" cooperation platform, strengthen the overall, grasp the key, take the lead, ensure the elements, and attack the difficulties, improve the joint promotion mechanism of the new pharmaceutical industry, and carry out cooperation and negotiation around the drug batch number resources and advantage projects, We will increase investment attraction; accelerate the establishment of a provincial platform for collaborative innovation of major new drugs, strengthen the introduction and training of talents, and enhance the ability of independent innovation; strengthen industrial policy support and industry supervision and guidance, and improve the efficiency of administrative services According to the requirements of the meeting, all departments and relevant enterprises shall, in combination with the division of responsibilities, work out and implement the implementation opinions of the opinions and the plan as soon as possible; allocate key forces to do a good job in the centralized commencement ceremony of new pharmaceutical industry projects in the whole province; plan ahead the investment promotion conference of new pharmaceutical industry in March next year to ensure high-level and high-quality outstanding completion of tasks At the meeting, the provincial economic and Information Technology Commission and ICBC provincial branch signed the strategic cooperation agreement on the development of new pharmaceutical industry, and eight units including the Provincial Department of science and technology made exchange speeches News extension > Industrial and Commercial Bank of China Guizhou branch granted 20 billion yuan to support the development of new medicine in Guizhou Province On October 8, Guizhou branch of industrial and Commercial Bank of China signed a strategic cooperation agreement with the provincial economic and Information Commission to support the development of Guizhou new medicine with a credit of 20 billion yuan At the same time, eight departments and units including the financial office of the provincial government, the Department of human resources and social security of Guizhou Province made a statement at the meeting, which will help the development of Guizhou new medicine in terms of funds and policies, Speed up the development of new medicine in Guizhou Province   In August 2014, Guizhou Province issued a three-year development plan for the new pharmaceutical industry, and set a development goal: by 2017, the total output value of the new pharmaceutical industry in Guizhou Province will exceed 80 billion yuan, forming more than one 10 billion yuan pharmaceutical industry group, more than one 5 billion yuan pharmaceutical industry group, more than 10 2 billion yuan pharmaceutical industry groups, and cultivating 3 2 billion yuan pharmaceutical varieties, 10 billion yuan pharmaceutical varieties, etc At the Guizhou new medicine industry development meeting held on October 8, Guizhou branch of industrial and Commercial Bank of China granted 20 billion yuan of credit to support the development of new medicine in Guizhou Province At present, nearly half of the pharmaceutical enterprises with an output value of more than 50 million yuan in Guizhou Province have cooperated with the bank As of September this year, the bank has provided more than 4 billion yuan of loan to support the new medicine industry in Guizhou Province   The financial office of the provincial government said that in the future, it will carry out the docking of financial enterprises, fully integrate the resources of commercial banks and financing guarantee institutions, and lead professional teams in the field of guarantee companies and medicine to help banks identify risks and reduce risks, and provide loan assistance to small and medium-sized new pharmaceutical enterprises in Guizhou Province; guide social capital to jointly initiate the establishment of Guizhou pharmaceutical industry investment fund, and cooperate with Tian We will make investment funds, venture capital funds, private equity funds, industrial investment funds, etc jointly build a multi-level investment system The Provincial Department of human resources and social security said that in vigorously developing the new pharmaceutical industry in Guizhou Province, we should pay attention to improving the research and development ability and clinical promotion and use of Guizhou drugs, and improve the success rate of Guizhou drugs in the expert selection stage The direct application of ethnic medicine shall be included in the scope of local medical insurance drug catalogue We will vigorously promote Guizhou drugs, including Miao drugs, to enter the scope of national ethnic drugs, strengthen the research on the basic theoretical system of Miao drugs, improve the research level of ethnic drugs, and obtain the national identity as soon as possible At present, among the exclusive varieties of medicine produced in Guizhou Province, 28 have been included in the national medical insurance drug catalog, and 76 have been included in the Guizhou medical insurance drug catalog The Provincial Department of science and technology has invested 90.6563 million yuan this year Through organizing and implementing science and technology projects, cultivating and building research and development platforms, it strives to build a new pharmaceutical industry technology innovation system based on industry university research cooperation, with enterprises as the main body, scientific research institutes as the support, market-oriented and products as the core Increase support for famous Miao medicine brands such as Yibai, bailing, magic, Tongjitang and Xinbang In the future, the Department will build Guizhou's medicine superior varieties, build a Chinese medicine base supported by science and technology, etc to boost the development of Guizhou's new medicine For example, in the aspect of building Guizhou's medicine superior varieties, it will cultivate Gastrodia elata, Eucommia ulmoides, pseudoginseng, Pinellia ternate, Dendrobium officinale, Polygonum capitatum, epimedium, Polygonum multiflorum, dipsacum, uncaria, etc with both resource advantages and industrial basis Species to create a big brand of medicinal materials, strive for more than 20 varieties with a market share of 20% in 2015, including more than 10 large varieties of Chinese medicinal materials     The tax department will also promote the development of new pharmaceutical industry in Guizhou Province in terms of policies: for the newly invested and registered pharmaceutical enterprises in Guizhou Province with an investment of more than 10 million yuan, the local value-added tax departments paid by the enterprises shall be fully subsidized to the enterprises by the municipal and county governments where the enterprises are located within 3 years and less than 5 years after the projects are put into operation, they shall be supported by half reduction If it holds or is recognized as a high-tech enterprise, the enterprise income tax shall be levied at a reduced rate of 15%   In addition, there are also incentive policies for pharmaceutical enterprises in Guizhou Province For example, if the enterprises in Guizhou Province successfully merge and acquire enterprises outside Guizhou Province and move their factories to Guizhou Province, the provincial one-off reward is 2 million yuan, and the municipal and county governments where the enterprises are located reward 3 million yuan If the enterprises in Guizhou Province merge and acquire enterprises in Guizhou Province and large varieties that pass the national Chinese medicine re evaluation, the provincial one-off reward is 1 million yuan, and the local government reward is 2 million yuan, etc 。 At the new medicine industry development meeting in Guizhou Province, it was emphasized that through the efforts of relevant departments, units and local governments in Guizhou Province, the new medicine business card of Guizhou Province should be made into a brand-new one with heavy gold content within three years Wang Jiangping, vice governor of Guizhou Province, attended and addressed the new medicine industry development conference in Guiyang, and he Li, vice governor, presided over the conference